Manage Cookies

A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.

  1. Strictly necessary cookies(always on):
    Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language

  2. Analytics cookies:
    Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics

  3. Social media cookies:
    We use social media cookies from Facebook, Twitter and Google to run Widgets, Embed Videos, Posts, Comments and to fetch profile information.

No analytics or social cookies have been enabled on this site. There are no cookies to review.

Deciding What Drugs Will Be Covered

14 May 2019
CLOSED: This discussion has concluded.

Pharmacare is a system of health insurance that provides people with access to necessary prescription drugs. The scope of drugs eligible for coverage through a pharmacare plan can vary.

One approach would be to limit coverage to those prescription drugs for which there is good evidence of both effectiveness and value-for-money. This approach would result in a less costly plan, but provide fewer options for some patients. 

Another approach would be to expand the list of covered drugs to include those for which there is less evidence of value-for-money, e.g., to include higher-cost drugs that may have little clinical evidence supporting how well they work. This approach would result in a more costly plan, but provide more options for some patients.

How extensive a selection of drugs should be covered under a national pharmacare program? Share your thoughts below:

Thank you for your interest in this consultation with the Advisory Council on the Implementation of National Pharmacare. 

The online consultation is now closed, and written submissions are no longer being accepted. 

In March 2019, the Council provided an interim report to the Minister of Health and the Minister of Finance on the progress of their work.

The Council released its final report in June 2019.

For more information on the Council, please visit the following link: www.canada.ca/pharmacare.

Keep in touch with us via email at pharmacare-assurancemedicaments@canada.ca

Sincerely,

Advisory Council on the Implementation of National Pharmacare


    <span class="translation_missing" title="translation missing: en.projects.forum_topics.show.load_comment_text">Load Comment Text</span>